These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26013384)

  • 1. Structural Identification of a Non-Glycosylated Variant at Ser126 for O-Glycosylation Site from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis.
    Byeon J; Lim YR; Kim HH; Suh JK
    Mol Cells; 2015 Jun; 38(6):496-505. PubMed ID: 26013384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural identification of modified amino acids on the interface between EPO and its receptor from EPO BRP, human recombinant erythropoietin by LC/MS analysis.
    Song KE; Byeon J; Moon DB; Kim HH; Choi YJ; Suh JK
    Mol Cells; 2014 Nov; 37(11):819-26. PubMed ID: 25284312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric glycoform profiling of the innovator and biosimilar erythropoietin and darbepoetin by LC/ESI-MS.
    Harazono A; Hashii N; Kuribayashi R; Nakazawa S; Kawasaki N
    J Pharm Biomed Anal; 2013 Sep; 83():65-74. PubMed ID: 23708432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of glycopeptide mapping by liquid chromatography/mass spectrometry in comparability assessment of glycoprotein products.
    Ohta M; Kawasaki N; Itoh S; Hayakawa T
    Biologicals; 2002 Sep; 30(3):235-44. PubMed ID: 12217347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for addition of O-linked carbohydrate to recombinant erythropoietin.
    Elliott S; Bartley T; Delorme E; Derby P; Hunt R; Lorenzini T; Parker V; Rohde MF; Stoney K
    Biochemistry; 1994 Sep; 33(37):11237-45. PubMed ID: 7727375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective glycopeptide mapping of erythropoietin by on-line high-performance liquid chromatography--electrospray ionization mass spectrometry.
    Ohta M; Kawasaki N; Hyuga S; Hyuga M; Hayakawa T
    J Chromatogr A; 2001 Feb; 910(1):1-11. PubMed ID: 11263562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry.
    Gong B; Burnina I; Stadheim TA; Li H
    J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low LC-MS/MS detection of glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow HPLC-chip electrospray ionization.
    Groleau PE; Desharnais P; Coté L; Ayotte C
    J Mass Spectrom; 2008 Jul; 43(7):924-35. PubMed ID: 18563860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment mass spectrometry.
    Sasaki H; Ochi N; Dell A; Fukuda M
    Biochemistry; 1988 Nov; 27(23):8618-26. PubMed ID: 3219367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific qualitative and quantitative analysis of the N- and O-glycoforms in recombinant human erythropoietin.
    Jiang J; Tian F; Cai Y; Qian X; Costello CE; Ying W
    Anal Bioanal Chem; 2014 Oct; 406(25):6265-74. PubMed ID: 25080026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
    Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
    J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual N-glycosylation of a recombinant human erythropoietin expressed in a human lymphoblastoid cell line does not alter its biological properties.
    Cointe D; Béliard R; Jorieux S; Leroy Y; Glacet A; Verbert A; Bourel D; Chirat F
    Glycobiology; 2000 May; 10(5):511-9. PubMed ID: 10764840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of N- and O-glycopeptides of recombinant human erythropoietins as potential biomarkers for doping analysis by means of microscale sample purification combined with MALDI-TOF and quadrupole IT/RTOF mass spectrometry.
    Stübiger G; Marchetti M; Nagano M; Grimm R; Gmeiner G; Reichel C; Allmaier G
    J Sep Sci; 2005 Sep; 28(14):1764-78. PubMed ID: 16224972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of recombinant human erythropoietin glycopeptides by capillary electrophoresis electrospray-time of flight-mass spectrometry.
    Giménez E; Ramos-Hernan R; Benavente F; Barbosa J; Sanz-Nebot V
    Anal Chim Acta; 2012 Jan; 709():81-90. PubMed ID: 22122935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Strategy Reveals Complex Glycosylation of Erythropoietin Using Mass Spectrometry.
    Guan Y; Zhang M; Gaikwad M; Voss H; Fazel R; Ansari S; Shen H; Wang J; Schlüter H
    J Proteome Res; 2021 Jul; 20(7):3654-3663. PubMed ID: 34110173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.
    Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H
    Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of liquid chromatography/mass spectrometry and liquid chromatography with tandem mass spectrometry to the analysis of the site-specific carbohydrate heterogeneity in erythropoietin.
    Kawasaki N; Ohta M; Hyuga S; Hyuga M; Hayakawa T
    Anal Biochem; 2000 Oct; 285(1):82-91. PubMed ID: 10998266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production.
    Wang Q; Chung CY; Yang W; Yang G; Chough S; Chen Y; Yin B; Bhattacharya R; Hu Y; Saeui CT; Yarema KJ; Betenbaugh MJ; Zhang H
    Biotechnol J; 2019 Apr; 14(4):e1800186. PubMed ID: 30221828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the combined effects of pegylation and glycosylation on the stability of erythropoietin using a stability-indicating SE-HPLC.
    Abed HS; Al-Ghobashy MA; Fathalla FA; Salem MY
    Biologicals; 2017 Nov; 50():129-136. PubMed ID: 28958787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Attribute Monitoring of Complex Erythropoetin Beta Glycosylation by GluC Liquid Chromatography-Mass Spectrometry Peptide Mapping.
    Buettner A; Maier M; Bonnington L; Bulau P; Reusch D
    Anal Chem; 2020 Jun; 92(11):7574-7580. PubMed ID: 32426963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.